Elevated amylin levels are typically associated with dysglycemia and pancreatic beta-cell dysfunction in Type 2 diabetes (Koda et al., 1992; Lorenzo et al., 1994; Ye et al., 2001). This evidence concerns the gene IAPP and type 2 diabetes mellitus.